Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beyondspring Inc

1.87
-0.1400-6.97%
Post-market: 1.870.00000.00%16:10 EDT
Volume:23.06K
Turnover:44.32K
Market Cap:75.42M
PE:-63.35
High:1.96
Open:1.96
Low:1.86
Close:2.01
52wk High:3.44
52wk Low:0.9800
Shares:40.33M
Float Shares:30.22M
Volume Ratio:0.30
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0295
EPS(LYR):-0.2799
ROE:-310.48%
ROA:-20.74%
PB:-2.50
PE(LYR):-6.68

Loading ...

Decheng Capital China Life Sciences USD Fund III, L.P. Reports Sale of BeyondSpring Inc. Common Shares

Reuters
·
Oct 21

Decheng Capital China Life Sciences USD Fund III, L.P. Reports Disposal of Common Shares of BeyondSpring Inc

Reuters
·
Oct 16

Decheng Capital China Life Sciences USD Fund III, L.P. Reports Disposal of Common Shares of BeyondSpring Inc

Reuters
·
Oct 08

Decheng Capital China Life Sciences USD Fund III, L.P. Reports Disposal of Common Shares of BeyondSpring Inc

Reuters
·
Oct 03

Decheng Capital China Life Sciences USD Fund III, L.P. Reports Disposal of Common Shares of BeyondSpring Inc

Reuters
·
Sep 30

Decheng Capital China Life Sciences USD Fund III, L.P. Reports Disposal of Common Shares of BeyondSpring Inc

Reuters
·
Sep 24

Decheng Capital China Life Sciences USD Fund III, L.P. Reports Disposal of Common Shares of BeyondSpring Inc

Reuters
·
Sep 12

Decheng Capital China Life Sciences USD Fund III, L.P. Reports Disposal of BeyondSpring Inc. Common Shares

Reuters
·
Sep 09

Decheng Capital China Life Sciences USD Fund III, L.P. Reports Disposal of Common Shares of BeyondSpring Inc

Reuters
·
Sep 04

Decheng Capital Reports Disposal of Common Shares in BeyondSpring Inc

Reuters
·
Aug 29

Decheng Capital China Life Sciences USD Fund III, L.P. Reports Disposal of Common Shares of BeyondSpring Inc

Reuters
·
Aug 26

Decheng Capital China Life Sciences USD Fund III, L.P. Reports Disposal of Common Shares in BeyondSpring Inc

Reuters
·
Aug 21

Decheng Capital Reports Disposal of Common Shares in BeyondSpring Inc

Reuters
·
Aug 16

BeyondSpring Q2 EPS $(0.04) Up From $(0.10) YoY

Benzinga
·
Aug 13

BeyondSpring Inc. Reports Q2 2025 Results: Net Loss Narrows to $1.9M, G&A Expenses Down by $0.9M

Reuters
·
Aug 13

BeyondSpring Reports Second‑Quarter 2025 Financial Results and Provides Corporate Update: Accelerates Momentum with Promising Clinical Advances and Strategic Leadership Appointment

GlobeNewswire
·
Aug 13

Decheng Capital Reports Disposal of Common Shares of BeyondSpring Inc

Reuters
·
Aug 12

BeyondSpring Publishes Human Clinical Study in Med (Cell Press) Showing Plinabulin-Driven Dendritic Cell Maturation and Tumor Response After Prior Checkpoint Inhibitor Failure

GlobeNewswire
·
Jul 07

Press Release: BeyondSpring Announces Poster Presentation at 2025 ASCO Annual Meeting

Dow Jones
·
May 28

BeyondSpring Q1 EPS $(0.08) Down From $0.11 YoY

Benzinga
·
May 13